MicroRNA (miRNA) profiles, small ribonucleic acid (RNA) sequences, may serve as innovative biomarkers to aid decision-making in the treatment of patients with respiratory diseases.

Thanks to two recent studies led from Lleida Two recent studies led from Lleida have shed light on the mechanisms associated with the persistence of pulmonary sequelae in critically ill COVID-19 patients. The research, which has been published in the scientific journals “ …

The implementation of telemedicine during the COVID-19 pandemic made it possible to maintain care for pregnant women and the postpartum period given the limitations imposed on attendance at the health centre.

A study has identified a 4-microRNA signature that improves early prediction of mortality in critically ill COVID-19 patients. The results of the research, led by several groups of the CIBER area of Respiratory Diseases (CIBERES), with the participation of research staff …

A new study reveals the importance of the 'viral storm' in critical patients with COVID-19.

This clinical tool, CIBERESUCICOVID SCORE, will select patients who may be more likely to have complications for respiratory follow-up in post-COVID units …

A new study within the CIBERESUCICOVID project highlights the usefulness of bronchial aspirate samples, obtained during the ICU stay, as a source of molecular information in COVID-19 patients assisted by invasive mechanical ventilation. More specifically, the study – coordinated by David de Gonzalo-Calvo, CIBERES …

Researchers at the University of Lleida (UdL) and the Biomedical Research Institute of Lleida (IRBLleida) have developed a free application to monitor the SARS-CoV-2 pandemic. Created as part of the UdL’s IlerCOVID research project, COVIDWORLD allows the current situation of the virus in 238 Spanish …

“RBD Dimer recombinant protein vaccine against SARSCoV2” (RBDCOV) is a new Horizon Europe project led by the biotech pharmaceutical company HIPRA. Launched on 1st December, RBDCOV project objective is to test the efficacy, tolerability, and safety of the HIPRA’s recombinant …

Research from Lleida has confirmed the improvement in the respiratory health of patients with chronic obstructive pulmonary disease (COPD) during home confinement in March, April and May 2020. Of the 310 people contacted in this study, 62% had fewer exacerbations, especially moderate and severe, than …